UPDATE - Canaccord Genuity Initiates Coverage on The Finish Line (FINL) with a Buy; A Comp Story Leveraging the Cycle
Tweet
Share
E-mailGet Alerts FINL Hot Sheet
Price: $13.51 --0%
Rating Summary:
3 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity initiates coverage on The Finish Line (Nasdaq: FINL) with a Buy. PT $24.
Canaccord analyst, Camilo Lyon, said, "We believe FINL is well positioned to continue benefiting from the running footwear cycle while also driving EBIT margin expansion. FINL has done well over the past two years to right-size its margin structure and improve its cost efficiency."
"Strategic acquisitions should help drive growth. FINL recently acquired The Running Company. This small acquisition could become meaningful one day. We like this small, methodical approach to acquisitions given the difficulty the company has had in the past."
To see more ratings changes on FINL, Click Here
Canaccord analyst, Camilo Lyon, said, "We believe FINL is well positioned to continue benefiting from the running footwear cycle while also driving EBIT margin expansion. FINL has done well over the past two years to right-size its margin structure and improve its cost efficiency."
"Strategic acquisitions should help drive growth. FINL recently acquired The Running Company. This small acquisition could become meaningful one day. We like this small, methodical approach to acquisitions given the difficulty the company has had in the past."
To see more ratings changes on FINL, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
- D. Boral Capital Starts Eve Holding Inc. (EVEX) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
